<DOC>
	<DOCNO>NCT03005106</DOCNO>
	<brief_summary>The propose registration study design phase III open-label , control , randomize , multicenter study evaluate efficacy safety StrataGraft skin tissue promote autologous skin tissue regeneration complex skin defect due thermal burn . The propose study include patient 3-49 % total body surface area ( TBSA ) complex skin defect due thermal burn intact dermal element excision autografting clinically indicate . The study design focus evaluation efficacy safety StrataGraft skin tissue , also assess potential StrataGraft skin tissue promote heal complex skin defect due thermal burn alternative donor site harvest autografting . Targeted enrollment study 70 subject complex skin defect cause thermal burn contain intact dermal element surgical excision autograft clinically indicate .</brief_summary>
	<brief_title>StrataGraft® Skin Tissue Promotion Autologous Skin Regeneration Complex Skin Defects Due Thermal Burns That Contain Intact Dermal Elements</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Burns</mesh_term>
	<criteria>Inclusion Criteria Subjectspecific criterion : 1 . Men woman age ≥ 18 year 2 . Written inform consent 3 . Sufficient healthy skin identify reserve donor site event StrataGraft treatment site require autografting 4 . Clinical expectation study donor site heal without graft 5 . Complex skin defect 349 % TBSA Total burn may consist one area Treatment sitespecific criterion : 6 . Thermal burn ( ) intact dermal element excision autografting clinically indicate 7 . Total study treatment area 2000 cm2 8 . First excision graft study treatment sit 9 . Thermal burn ( ) torso , arm , legs Exclusion Criteria Subjectspecific criterion : 1 . Pregnant woman 2 . Prisoners 3 . Subjects receive systemic immunosuppressive therapy 4 . Subjects know history malignancy 5 . Preadmission insulindependent diabetic subject 6 . Subjects concurrent condition opinion investigator may compromise subject safety study objectives 7 . Expected survival less three month 8 . Participation treatment group interventional study within 90 day prior enrollment Treatment sitespecific criterion : 9 . Fullthickness burn 10 . Chronic wound 11 . The face , head , neck , hand , foot , buttock , area joint 12 . Treatment sit immediately adjacent unexcised eschar 13 . Clinical laboratory determination infection anticipate treatment site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>